Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics

被引:291
作者
Ding, Dawei [1 ]
Zhu, Qingdi [1 ]
机构
[1] SMART Ctr, BioSyst & Micromech BioSyM IRG, 1 CREATE Way,Enterprise Wing, Singapore 138602, Singapore
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2018年 / 92卷
关键词
PLGA; Drug delivery; Protein and nucleic acid; Controlled and stimuli-responsive release; FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; STIMULI-RESPONSIVE NANOCARRIERS; CONTROLLED DRUG-DELIVERY; IN-VITRO; POLYMERIC NANOPARTICLES; CO-DELIVERY; GENE DELIVERY; POLY(LACTIC-CO-GLYCOLIC ACID); SUSTAINED-RELEASE;
D O I
10.1016/j.msec.2017.12.036
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Recent advancements in biopharmaceutical industry have facilitated the development of novel bioactive macromolecular therapeutics. One of the challenges towards the clinical use of these biomacromolecules lies in the selection of appropriate carriers to protect, deliver and release them in vivo to maximize their pharmacological effects. Micro/nanoparticles made from biodegradable poly (D,L-lactic-co-glycolic acid) (PLGA) have been explored as delivery vehicles for therapeutics. Due to their excellent biocompatibility and controllable biodegradability, PLGA micro/nanoparticles could protect macromolecules from instant degradation in vivo while allowing tunable release rate and profile. In this review, recent progress in the design, fabrication/formulation and application of PLGA based micro/nanoparticles for the controlled delivery of biomacromolecules are discussed. Special focuses will be on the novel loading methods and releasing mechanisms of macromolecules as well as the in vivo applications of therapeutic macromolecule-loaded PLGA micro/nanoparticles.
引用
收藏
页码:1041 / 1060
页数:20
相关论文
共 250 条
[1]   Mechanisms of allergen-specific immunotherapy [J].
Akdis, Cezmi A. ;
Akdis, Muebeccel .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) :18-27
[2]  
Alarcon J. B., 1999, ADV PARASIT, P343
[3]   Peptide/protein vaccine delivery system based on PLGA particles [J].
Allahyari, Mojgan ;
Mohit, Elham .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) :806-828
[4]   Surface functionalisation of PLGA nanoparticles for gene silencing [J].
Andersen, Morten O. ;
Lichawska, Agata ;
Arpanaei, Ayyoob ;
Jensen, Stig Moller Rask ;
Kaur, Harpreet ;
Oupicky, David ;
Besenbacher, Flemming ;
Kingshott, Peter ;
Kjems, Jorgen ;
Howard, Kenneth A. .
BIOMATERIALS, 2010, 31 (21) :5671-5677
[5]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[6]   Cytokine treatment in cancer immunotherapy [J].
Ardolino, Michele ;
Hsu, Joy ;
Raulet, David H. .
ONCOTARGET, 2015, 6 (23) :19346-19347
[7]   Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine [J].
Bae, Soon Eon ;
Son, Jun Sik ;
Park, Kwideok ;
Han, Dong Keun .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (01) :37-43
[8]   Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers [J].
Bae, Younsoo ;
Kataoka, Kazunori .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (10) :768-784
[9]   PLGA nanoparticles in drug delivery: The state of the art [J].
Bala, I ;
Hariharan, S ;
Kumar, MNVR .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (05) :387-422
[10]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252